Cancers
About this category
The analysis of disorders in genes associated with the development of cancers can be assessed by identifying germinal (hereditary) and somatic (non-inherited) mutations.
Identification of the germinal mutation allows to determine the probability of developing the disease in a healthy patient with a family history of cancers, allowing for taking preventive measures. Identification of a germinal mutation in a patient suffering from cancer may allow for the determination of appropriate therapy and provides information about the possibility of passing the mutation on to children. Indication of somatic mutations also allows the implementation of an appropriate treatment plan for the patient.
All genetic tests are performed using the next-generation sequencing method, using Illumina sequencers. Our tests are subject to internal and external control. The laboratory is subject to continuous external quality control.
Panels in this category
47 panels-
AKT1, PIK3CA, PTEN - somatic profiling
3 genesAKT1; PIK3CA; PTEN
1994 PLNDetails -
Ataraxis Breast CTX
1 gene3300 PLNDetails -
Ataraxis Breast NEO
1 gene3300 PLNDetails -
Ataraxis Breast RISK
1 gene3300 PLNDetails -
Basal Cell Nevus syndrome
3 genesPTCH1; PTCH2; SUFU
1894 PLNDetails -
BRCA1, BRCA2 - dependent cancer - germinal variants
2 genesBRCA1; BRCA2
1494 PLNDetails -
BRCA1, BRCA2 - rak trzustki
2 genes1994 PLNDetails -
BRCA1, BRCA2 somatic profiling
2 genesBRCA1; BRCA2
1994 PLNDetails -
Breast and ovarian cancer
26 genesATM; BARD1; BRCA1; BRCA2; BRIP1; CDH1; CHEK2; DICER1; EPCAM; FANCC; MLH1; MSH2; MSH6; NBN; NF1; PALB2; PMS2; PTEN; RAD50; RAD51; RAD51C; RAD51D; STK11; TP53; XRCC2; XRCC3
2194 PLNDetails -
Breast and Ovarian Cancer - basic panel
8 genesATM; BRCA1; BRCA2; CDH1; CHEK2; PALB2; PTEN; TP53
2194 PLNDetails -
Breast and ovarian cancer - deletion by MLPA (BRCA1)
3 genesAKT1; PIK3CA; PTEN
1994 PLNDetails -
Breast and ovarian cancer - deletion by MLPA (BRCA2)
3 genesBRAF; KRAS; NRAS
1994 PLNDetails -
Breast, ovarian, endometrial cancer
21 genesATM; BARD1; BRCA1; BRCA2; CHEK2; EPCAM; MLH1; MRE11A; MSH2; MSH6; NBN; PALB2; PMS2; PPM1D; PTEN; RAD50; RAD51C; RAD51D; STK11; TP53; XRCC2
2194 PLNDetails -
Childhood cancers
47 genesALK; APC; AXIN2; BAP1; BLM; BMPR1A; CDC73; DICER1; DIS3L2; EPCAM; EZH2; FH; GATA2; HRAS; MAX; MEN1; MLH1; MSH2; MSH6; NBN; NF1; NF2; PMS2; PRF1; PRKAR1A; PTCH1; PTEN; RB1; RECQL4; RET; RUNX1; SDHA; SDHAF2; SDHB; SDHC; SDHD; SMAD4; SMARCB1; STK11; SUFU; TMEM127; TP53; TSC1; TSC2; VHL; WRN; WT1
2194 PLNDetails -
Chronic lymphocytic leukemia
17 genesATM; BCL2; BIRC3; BTK; CXCR4; DLEU1; EGR2; FBXW7; KRAS; MYD88; NFKBIE; NOTCH1; PLCG2; POT1; SF3B1; TP53; XPO1
2794 PLNDetails -
Colorectal cancer - basic panel
11 genesAPC; BMPR1A; EPCAM; MLH1; MSH2; MSH6; MUTYH; PMS2; PTEN; SMAD4; STK11
2194 PLNDetails -
Colorectal cancer Lynch syndrome included
28 genesAKT1; APC; ATM; AXIN2; BLM; BMPR1A; CDH1; CHEK2; CTNNA1; EPCAM; EXO1; GALNT12; GREM1; MLH1; MLH3; MSH2; MSH6; MUTYH; PIK3CA; PMS1; PMS2; POLD1; POLE; PTEN; SMAD4; STK11; TGFBR2; TP53
2194 PLNDetails -
Comprehensive Cancer Panel
Frequently chosen 70 genesAKT1; APC; ATM; AXIN2; BARD1; BMPR1A; BRCA1; BRCA2; BRIP1; CDC73; CDH1; CDKN1B; CDKN2A; CHEK2; CTNNA1; DICER1; EPCAM; FANCC; FH; GALNT12; GDNF; GREM1; HNF1A; HNF1B; HOXB13; KIF1B; MAX; MC1R; MEN1; MET; MITF; MLH1; MLH3; MRE11A; MSH2; MSH6; MUTYH; NBN; NF1; PALB2; PIK3CA; PMS2; POLD1; POLE; POT1; PRKAR1A; PRSS1; PTCH1; PTEN; RAD51C; RAD51D; RB1; RET; SDHA; SDHAF2; SDHB; SDHC; SDHD; SMAD4; STK11; TERT; TGFBR2; TMEM127; TP53; TSC1; TSC2; VHL; WT1; XRCC2; XRCC3
2194 PLNDetails -
Deletion by MLPA: BRCA1; BRCA2 (BG)
1 geneBRCA1
994 PLNDetails -
Deletion by MLPA: MLH1; MSH2 (BG)
2 genesMLH1; MSH2
1594 PLNDetails -
EGFR Gene Analysis from cfDNA (NGS)
4 genesALK; EGFR; KRAS; ROS1
1994 PLNDetails -
Endocrine tumors 1
22 genesAIP; APC; CDC73; CDKN1B; DICER1; FH; MAX; MEN1; MET; NF1; PRKAR1A; PTEN; RET; SDHA; SDHAF2; SDHB; SDHC; SDHD; TMEM127; TP53; VHL; WRN
2194 PLNDetails -
Endometrial cancer
11 genesBRCA1; BRCA2; CTNNB1; MLH1; MSH2; MSH6; PMS2; POLD1; POLE; PTEN; TP53
2194 PLNDetails -
Gastric cancer
9 genesBMPR1A; CDH1; EPCAM; MLH1; MSH2; MSH6; PMS1; PMS2; SMAD4
2194 PLNDetails -
Gastrointestinal cancer
38 genesAPC; ATM; AXIN2; BLM; BMPR1A; BRCA1; BRCA2; BUB1B; CDH1; CDKN2A; EPCAM; FANCC; GREM1; HNF1A; KIT; MEN1; MLH1; MSH2; MSH6; MUTYH; NF1; PALB2; PMS2; POLD1; POLE; PTEN; RHBDF2; SDHB; SDHC; SDHD; SMAD4; SMARCB1; STK11; TMEM127; TP53; TSC1; TSC2; VHL
2194 PLNDetails -
GIST, paraganglioma, pheochromocytoma
14 genesGDNF; MAX; MEN1; NF1; PRKAR1A; RET; SDHA; SDHAF2; SDHB; SDHC; SDHD; TMEM127; TP53; VHL
2194 PLNDetails -
Inflammation of the pancreas
4 genesCFTR; CTRC; PRSS1; SPINK1
1894 PLNDetails -
Leukemia
93 genesABL1; ANKRD26; ATM; BCR; BLM; BRAF; BRCA1; BRCA2; BRIP1; CALR; CBFB; CBL; CDKN2A; CEBPA; CHEK2; CHIC2; DDX41; DKC1; DNMT3A; EFTUD1; ELANE; EPCAM; ETV6; EZH2; FANCA; FANCB; FANCC; FANCD2; FANCE; FANCF; FANCG; FANCI; FANCL; FANCM; FGFR1; FIP1L1; FLT3; GATA2; HRAS; IDH1; IKZF1; JAK2; KIT; KMT2A; KRAS; LIFR; LPP; MAP2K1; MAP2K2; MLH1; MLLT10; MPL; MSH2; MSH6; MYH11; NBN; NF1; NPM1; NRAS; NUMA1; PALB2; PAX5; PDGFRA; PKLR; PML; PMS2; PRF1; PTPN11; RAD51C; RARA; RIT1; RMRP; RUNX1; RUNX1T1; SAMD9; SAMD9L; SBDS; SH3GL1; SLX4; SOS1; SRP72; STAT5B; STX11; STXBP2; TERC; TERT; TET2; TINF2; TP53; UNC13D; WT1; ZBTB16; ZMYM2
2194 PLNDetails -
Lynch syndrome
5 genesEPCAM; MLH1; MSH2; MSH6; PMS2
1894 PLNDetails -
Lynch syndrome - deletions by MLPA (MLH1and MSH2)
1 geneBRCA2
994 PLNDetails -
MSH2-colorectal cancer
1 geneMSH2
1894 PLNDetails -
Neurofibromatosis type I and II
9 genesKIT; KITLG; LZTR1; NF1; NF2; PTPN11; RAF1; SMARCB1; SPRED1
2194 PLNDetails -
Pancreatic cancer
12 genesATM; BRCA1; BRCA2; CDKN2A; MLH1; MSH2; MSH6; PALB2; PMS2; STK11; TP53; VHL
2194 PLNDetails -
Paraganglioma-Pheochromocytoma
11 genesFH; MAX; NF1; RET; SDHA; SDHAF2; SDHB; SDHC; SDHD; TMEM127; VHL
2194 PLNDetails -
PD-L1
1 geneCD274
594 PLNDetails -
POLE - endometrial cancer, colorectal cancer
1 genePOLE
1594 PLNDetails -
Prostate cancer
7 genesATM; BRCA1; BRCA2; CHEK2; HOXB13; NBN; TP53
2194 PLNDetails -
Prostate cancer - 11 HRR genes - SOMATIC MUTATIONS
6 genesBRCA1; BRCA2; EGFR; HRAS; KRAS; NRAS
2494 PLNDetails -
Prostate cancer - HRR somatic profiling
7 genesATM; BRCA1; BRCA2; CDK12; CHEK2; PALB2; RAD51C
2194 PLNDetails -
Renal cancer
26 genesBAP1; CDC73; DICER1; DIS3L2; EPCAM; FH; FLCN; HNF1A; HNF1B; MET; MITF; MLH1; MSH2; MSH6; PMS1; PMS2; PTEN; SDHB; SDHC; SDHD; SMARCB1; TP53; TSC1; TSC2; VHL; WT1
2194 PLNDetails -
Retinoblastoma
1 gene1894 PLNDetails -
Somatic mutation - monitoring
Frequently chosen 1 gene4494 PLNDetails -
somatic profiling - one gene
1 gene1694 PLNDetails -
Targeted therapy - EGFR, ALK, ROS1
4 genesALK; EGFR; KRAS; ROS1
1994 PLNDetails -
Thyroid cancer
11 genesAPC; CDC73; DICER1; MEN1; PRKAR1A; PTEN; RET; SDHB; SDHD; TP53; WRN
2194 PLNDetails -
Tuberous sclerosis
2 genesTSC1; TSC2
1894 PLNDetails -
Xeroderma Pigmentosum
7 genesDDB2; ERCC2; ERCC3; ERCC4; ERCC5; XPA; XPC
2194 PLNDetails
Not sure which test to choose?
Book a consultation with a clinical geneticist, or get in touch — we'll help you choose the right test.